OFFIDANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 1.012
AS - Asia 747
EU - Europa 609
SA - Sud America 199
AF - Africa 62
OC - Oceania 1
Totale 2.630
Nazione #
US - Stati Uniti d'America 981
VN - Vietnam 210
SG - Singapore 179
IT - Italia 173
BR - Brasile 145
CN - Cina 124
RU - Federazione Russa 124
HK - Hong Kong 105
DE - Germania 67
FR - Francia 51
CI - Costa d'Avorio 32
FI - Finlandia 32
GB - Regno Unito 29
AR - Argentina 27
IN - India 25
IE - Irlanda 23
SE - Svezia 23
UA - Ucraina 19
TR - Turchia 17
JP - Giappone 15
NL - Olanda 14
AT - Austria 13
MX - Messico 12
BD - Bangladesh 11
CA - Canada 9
DK - Danimarca 9
EC - Ecuador 9
MA - Marocco 9
SA - Arabia Saudita 8
ZA - Sudafrica 8
ID - Indonesia 7
IQ - Iraq 7
UZ - Uzbekistan 7
ES - Italia 6
CO - Colombia 5
PK - Pakistan 5
PL - Polonia 5
VE - Venezuela 5
HU - Ungheria 4
KR - Corea 4
SN - Senegal 4
BE - Belgio 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
Totale 2.630
Città #
Ashburn 258
Dallas 128
Singapore 109
Hong Kong 101
San Jose 84
Ho Chi Minh City 76
Hanoi 48
Boardman 42
The Dalles 34
Abidjan 32
Munich 31
Los Angeles 29
Council Bluffs 28
Chandler 26
Moscow 25
Dublin 23
Lauterbourg 23
New York 22
São Paulo 22
Beijing 21
Helsinki 20
Hefei 18
Rome 18
Frankfurt am Main 16
Jacksonville 15
Milan 15
Fairfield 14
Santa Clara 14
Wilmington 12
Da Nang 11
Denver 11
Orem 11
Seattle 10
Buffalo 9
Chennai 9
Nuremberg 9
Turin 9
Turku 9
Houston 8
Amsterdam 7
Brooklyn 7
Guangzhou 7
Mexico City 7
Tokyo 7
Ancona 6
Bari 6
Chicago 6
Tashkent 6
Woodbridge 6
Bologna 5
Cambridge 5
Falconara Marittima 5
Haiphong 5
Johannesburg 5
Lawrence 5
London 5
North Charleston 5
Princeton 5
Atlanta 4
Brescia 4
Camden 4
Dakar 4
Hải Dương 4
Ninh Bình 4
Rio de Janeiro 4
Warsaw 4
Washington 4
Ankara 3
Ann Arbor 3
Baghdad 3
Biên Hòa 3
Boston 3
Brussels 3
Buenos Aires 3
Caracas 3
Curitiba 3
Guayaquil 3
Holstebro 3
Huế 3
Magnesia ad Sipylum 3
Manchester 3
Medellín 3
Montreal 3
Mumbai 3
New Delhi 3
Pescara 3
Phoenix 3
Plano 3
Poplar 3
Quito 3
Quảng Ninh 3
San Mateo 3
Southwark 3
Thái Bình 3
Thái Nguyên 3
Wuxi 3
Altamura 2
Amman 2
Araçatuba 2
Asunción 2
Totale 1.641
Nome #
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 154
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 141
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 136
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 127
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 125
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 120
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study 119
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 118
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 111
Current Main Topics in Multiple Myeloma 110
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 104
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety 100
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 99
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 99
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 99
AL amyloidosis: an overview on diagnosis, staging system, and treatment 99
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 96
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences 94
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 93
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 92
Long-Term Survival with Multiple Myeloma: An Italian Experience 91
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients 89
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 79
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 64
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 60
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 52
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 41
Totale 2.712
Categoria #
all - tutte 9.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.269


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 3 6 3
2021/202232 2 3 2 1 0 1 5 3 1 2 6 6
2022/202387 5 11 7 3 4 11 0 4 18 0 24 0
2023/2024182 15 5 8 11 22 18 4 5 9 7 23 55
2024/2025549 40 27 21 6 12 33 40 25 130 80 57 78
2025/20261.743 145 135 169 174 188 179 367 145 107 134 0 0
Totale 2.712